Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Return on Assets (2016 - 2021)

Historic Return on Assets for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to 0.08%.

  • Phio Pharmaceuticals' Return on Assets rose 3900.0% to 0.08% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.08%, marking a year-over-year increase of 3900.0%. This contributed to the annual value of 0.74% for FY2020, which is 200.0% up from last year.
  • Latest data reveals that Phio Pharmaceuticals reported Return on Assets of 0.08% as of Q3 2021, which was up 3900.0% from 0.15% recorded in Q2 2021.
  • Phio Pharmaceuticals' 5-year Return on Assets high stood at 0.08% for Q3 2021, and its period low was 2.57% during Q1 2018.
  • For the 5-year period, Phio Pharmaceuticals' Return on Assets averaged around 1.0%, with its median value being 0.77% (2018).
  • Per our database at Business Quant, Phio Pharmaceuticals' Return on Assets crashed by -15500bps in 2018 and then skyrocketed by 20700bps in 2019.
  • Phio Pharmaceuticals' Return on Assets (Quarter) stood at 2.46% in 2017, then soared by 69bps to 0.77% in 2018, then decreased by -29bps to 0.99% in 2019, then surged by 48bps to 0.52% in 2020, then surged by 84bps to 0.08% in 2021.
  • Its Return on Assets was 0.08% in Q3 2021, compared to 0.15% in Q2 2021 and 0.26% in Q1 2021.